Related Experiment Video
Updated: Apr 23, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Patient-to-physician messaging: volume nearly tripled as more patients joined system, but per capita rate plateaued
Bradley H Crotty1, Yonas Tamrat2, Arash Mostaghimi3
1Bradley H. Crotty (bcrotty@bidmc.harvard.edu) is director of patient portals in the Division of Clinical Informatics, Beth Israel Deaconess Medical Center, and an instructor in medicine at Harvard Medical School, both in Boston, Massachusetts.
Abstract:
Patients want to be able to communicate with their physicians by e-mail. However, physicians are often concerned about the impact that such communications will have on their time, productivity, and reimbursement. Typically, physicians are not reimbursed for time spent communicating with patients electronically. But under federal meaningful-use criteria for information technology, physicians can receive a modest incentive for such communications. Little is known about trends in secure e-mail messaging between physicians and patients. To understand these trends, we analyzed the volume of messages in a large academic health system's patient portal in the period 2001-10. At the end of 2010, 49,778 patients (22.7 percent of all patients seen within the system) had enrolled in the portal, and 36.9 percent of enrolled patients (8.4 percent of all patients) had sent at least one message to a physician. Physicians in the aggregate saw a near tripling of e-mail messages during the study period. However, the number of messages per hundred patients per month stabilized between 2005 and 2010, at an average of 18.9 messages. As physician reimbursement moves toward global payments, physicians' and patients' participation in secure messaging will likely increase, and electronic communication should be considered part of physicians' job descriptions.
Related Concept Videos
Drug Dosing: Obese Patients
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Dosage Regimen: Individualization
Drug Distribution: Volume of Distribution
Types of Reports III: Telephone and Verbal Reports
Here's an overview of each type:
Telephone Orders

